VarroMed

RSS

oxalic acid dihydrate / formic acid

Authorised
This medicine is authorised for use in the European Union.

Overview

This is a summary of the European public assessment report (EPAR) for VarroMed.It explains how the Agency assessed this veterinary medicine to recommend its authorisation in the European Union (EU) and its conditions of use. It is not intended to provide practical advice on how to use VarroMed.

For practical information about using VarroMed, animal owners or keepers should read the package leaflet or contact their veterinarian or pharmacist.

This EPAR was last updated on 11/01/2022

Authorisation details

Product details
Name
VarroMed
Agency product number
EMEA/V/C/002723
Active substance
  • oxalic acid dihydrate
  • formic acid
International non-proprietary name (INN) or common name
oxalic acid dihydrate / formic acid
Species
Bees
Anatomical therapeutic chemical veterinary (ATCvet) codes
QP53AG30
Publication details
Marketing-authorisation holder
BeeVital GmbH
Revision
3
Date of issue of marketing authorisation valid throughout the European Union
02/02/2017
Contact address
Wiesenbergstrasse
5164 Seeham
Austria

Product information

04/01/2022 VarroMed - EMEA/V/C/002723 - R/0005

Other EU languages available icon This medicine’s product information is available in all official EU languages.
Select ‘available languages’ to access the language you need.

 

Product information documents contain:

You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.

Pharmacotherapeutic group

Ectoparasiticides for topical use, incl. insecticides

Therapeutic indication

Treatment of varroosis (Varroa destructor) in honey bee colonies with and without brood

Assessment history

How useful was this page?

Add your rating
Average
2 ratings